Literature DB >> 25580772

Optimal design in pediatric pharmacokinetic and pharmacodynamic clinical studies.

Jessica K Roberts1, Chris Stockmann, Alfred Balch, Tian Yu, Robert M Ward, Michael G Spigarelli, Catherine M T Sherwin.   

Abstract

It is not trivial to conduct clinical trials with pediatric participants. Ethical, logistical, and financial considerations add to the complexity of pediatric studies. Optimal design theory allows investigators the opportunity to apply mathematical optimization algorithms to define how to structure their data collection to answer focused research questions. These techniques can be used to determine an optimal sample size, optimal sample times, and the number of samples required for pharmacokinetic and pharmacodynamic studies. The aim of this review is to demonstrate how to determine optimal sample size, optimal sample times, and the number of samples required from each patient by presenting specific examples using optimal design tools. Additionally, this review aims to discuss the relative usefulness of sparse vs rich data. This review is intended to educate the clinician, as well as the basic research scientist, whom plan on conducting a pharmacokinetic/pharmacodynamic clinical trial in pediatric patients.
© 2015 John Wiley & Sons Ltd.

Entities:  

Keywords:  D-optimal design; analgesics; anesthetics; optimal design; pediatric; research design; sample size

Mesh:

Substances:

Year:  2015        PMID: 25580772     DOI: 10.1111/pan.12575

Source DB:  PubMed          Journal:  Paediatr Anaesth        ISSN: 1155-5645            Impact factor:   2.556


  11 in total

1.  Commentary on the EMA Reflection Paper on the use of extrapolation in the development of medicines for paediatrics.

Authors:  Cécile Ollivier; Andrew Thomson; Efthymios Manolis; Kevin Blake; Kristin E Karlsson; Catherijne A J Knibbe; Gérard Pons; Robert Hemmings
Journal:  Br J Clin Pharmacol       Date:  2019-02-28       Impact factor: 4.335

2.  Target attainment analysis and optimal sampling designs for population pharmacokinetic study on piperacillin/tazobactam in neonates and young infants.

Authors:  Yewei Chen; Jinmiao Lu; Min Dong; Dan Wu; Yiqing Zhu; Qin Li; Chao Chen; Zhiping Li
Journal:  Eur J Clin Pharmacol       Date:  2016-09-19       Impact factor: 2.953

3.  Population Pharmacokinetics of Teicoplanin in Preterm and Term Neonates: Is It Time for a New Dosing Regimen?

Authors:  A Kontou; K Sarafidis; O Begou; H G Gika; A Tsiligiannis; K Ogungbenro; A Dokoumetzidis; E Agakidou; E Roilides
Journal:  Antimicrob Agents Chemother       Date:  2020-03-24       Impact factor: 5.191

4.  Population Pharmacokinetics of Dexmedetomidine After Short Intravenous Infusion in Chinese Children.

Authors:  Hua-Cheng Liu; Qing-Quan Lian; Fei-Fei Wu; Cheng-Yu Wang; Wei Sun; Li-Dan Zheng; Jürgen Schüttler; Harald Ihmsen
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2017-04       Impact factor: 2.441

5.  Use of Modeling and Simulation in the Design and Conduct of Pediatric Clinical Trials and the Optimization of Individualized Dosing Regimens.

Authors:  C Stockmann; J S Barrett; J K Roberts; Cmt Sherwin
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2015-11-13

Review 6.  Pharmacokinetic studies in children: recommendations for practice and research.

Authors:  Charlotte I S Barker; Joseph F Standing; Lauren E Kelly; Lauren Hanly Faught; Allison C Needham; Michael J Rieder; Saskia N de Wildt; Martin Offringa
Journal:  Arch Dis Child       Date:  2018-04-19       Impact factor: 3.791

Review 7.  Pharmacokinetic-Pharmacodynamic Modeling in Pediatric Drug Development, and the Importance of Standardized Scaling of Clearance.

Authors:  Eva Germovsek; Charlotte I S Barker; Mike Sharland; Joseph F Standing
Journal:  Clin Pharmacokinet       Date:  2019-01       Impact factor: 5.577

Review 8.  Generating Robust and Informative Nonclinical In Vitro and In Vivo Bacterial Infection Model Efficacy Data To Support Translation to Humans.

Authors:  Jürgen B Bulitta; William W Hope; Ann E Eakin; Tina Guina; Vincent H Tam; Arnold Louie; George L Drusano; Jennifer L Hoover
Journal:  Antimicrob Agents Chemother       Date:  2019-04-25       Impact factor: 5.191

9.  Clinical Pharmacokinetics of Oral Sodium Selenite and Dosing Implications in the Treatment of Patients with Metastatic Cancer.

Authors:  Priya Jayachandran; Susan J Knox; Maria Garcia-Cremades; Radojka M Savić
Journal:  Drugs R D       Date:  2021-04-17

Review 10.  How to optimise drug study design: pharmacokinetics and pharmacodynamics studies introduced to paediatricians.

Authors:  Eric Vermeulen; John N van den Anker; Oscar Della Pasqua; Kalle Hoppu; Johanna H van der Lee
Journal:  J Pharm Pharmacol       Date:  2016-09-27       Impact factor: 3.765

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.